Normally, I don’t begin a piece with a graphic. Especially not one as involved as this snapshot by the Kaiser Family Foundation of how Medicare’s Part D prescription drug program would change under provisions of a measure slowly wending through the U.S. Senate.
0 subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.